Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 17 May 1996:
Vol. 272. no. 5264, pp. 954 - 0
DOI: 10.1126/science.272.5264.954

Research News

Trisha Gura

The proteins known as chemokines achieved public fame late last year, as a result of work suggesting that they might help protect against AIDS. But the proteins have a much wider role than that. As magnets for white blood cells, they play a key role in in flammatory responses and thus in the body's defenses against a wide array of invading pathogens. What's more, chemokine effects can also backfire, and contribute to a wide range of inflammatory diseases, such as rheumatoid arthritis, asthma, and adult res piratory distress syndrome, a major killer characterized by fluid buildup in the lungs. As a result, the chemokines have become major targets of efforts to develop new anti-inflammatory therapies, and recent work is already producing some promising result s.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Protein Kinase C{alpha}-RhoA Cross-talk in CCL2-induced Alterations in Brain Endothelial Permeability.
S. M. Stamatovic, O. B. Dimitrijevic, R. F. Keep, and A. V. Andjelkovic (2006)
J. Biol. Chem. 281, 8379-8388
   Abstract »    Full Text »    PDF »
Chemokines, innate and adaptive immunity, and respiratory disease.
I. Sabroe, C.M. Lloyd, M.K.B. Whyte, S.K. Dower, T.J. Williams, and J.E. Pease (2002)
Eur. Respir. J. 19, 350-355
   Abstract »    Full Text »    PDF »
High Cancer Cell Death in Syngeneic Tumors Developed in Host Mice Deficient for the Stromelysin-3 Matrix Metalloproteinase.
A. Boulay, R. Masson, M.-P. Chenard, M. El Fahime, L. Cassard, J.-P. Bellocq, C. Sautèes-Fridman, P. Basset, and M.-C. Rio (2001)
Cancer Res. 61, 2189-2193
   Abstract »    Full Text »
Differential Regulation of Eosinophil Chemokine Signaling Via CCR3 and Non-CCR3 Pathways.
I. Sabroe, A. Hartnell, L. A. Jopling, S. Bel, P. D. Ponath, J. E. Pease, P. D. Collins, and T. J. Williams (1999)
J. Immunol. 162, 2946-2955
   Abstract »    Full Text »    PDF »
Cloning and Characterization of the Guinea Pig Eosinophil Eotaxin Receptor, C-C Chemokine Receptor-3: Blockade Using a Monoclonal Antibody In Vivo.
I. Sabroe, D. M. Conroy, N. P. Gerard, Y. Li, P. D. Collins, T. W. Post, P. J. Jose, T. J. Williams, C. J. Gerard, and P. D. Ponath (1998)
J. Immunol. 161, 6139-6147
   Abstract »    Full Text »    PDF »
Severity of Airflow Limitation Is Associated with Severity of Airway Inflammation in Smokers.
A. DI STEFANO, A. CAPELLI, M. LUSUARDI, P. BALBO, C. VECCHIO, P. MAESTRELLI, C. E. MAPP, L. M. FABBRI, C. F. DONNER, and M. SAETTA (1998)
Am. J. Respir. Crit. Care Med. 158, 1277-1285
   Abstract »    Full Text »    PDF »
Searching for Chemokine Receptor Binding Antagonists by High Throughput Screening.
G. W. Mellor, S. J. Fogarty, M. S. O'Brien, M. Congreve, M. N. Banks, K. M. Mills, B. Jefferies, and J. G. Houston (1997)
J Biomol Screen 2, 153-157
   Abstract »    PDF »
A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3. POTENT INHIBITION OF EOSINOPHIL FUNCTION AND CCR3-MEDIATED HIV-1 ENTRY.
I. Sabroe, M. J. Peck, B. J. Van Keulen, A. Jorritsma, G. Simmons, P. R. Clapham, T. J. Williams, and J. E. Pease (2000)
J. Biol. Chem. 275, 25985-25992
   Abstract »    Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)